Your.MD, the only personal health assistant that harnesses Artificial Intelligence (AI), is now available to users on global messenger platforms for the first time. The news comes as Your.MD reveals it has become the number one health app in over 40 countries since its launch in November 2015 (1) including India, the Philippines and Nigeria.

Brainlab AG, a global leader in cancer-fighting medical technology, showed solidarity with the World Cancer Day campaign 'We Can. I Can.' by releasing a video in which employees share how they personally impact cancer. The three-year World Cancer Day campaign, outlines actions that people can take to prevent cancer, improve survival rates and reduce the impact cancer has on individuals, families and communities.

The EU-funded FICHe accelerator is joining Health 2.0 Euope 2016 as a pavilion exhibitor. All 20 FICHe finalist will show their demo at the exhibition floor, some of them will pitch in front of investors, others will present on the main stage. Meet 20 FICHe finalist startups and many more key stakeholders in digital health.

Hearst Health International announced that OptimiseRx has become the first solution to be procured by a federation of five London Clinical Commissioning Groups (CCGs) under a new procurement framework from NHS Shared Business Services (NHS SBS).

Diabetes Tools has been nominated for Best Mobile Innovation for Health in the GSMA's 2016 Global Mobile Awards for its TriabetesClinic online decision support service that puts medical apps at the heart of diabetes treatment for insulin-dependent children, both in hospital and remotely at home.

This week sees the release of the latest version of the IMS MAXIMS open source electronic patient record (EPR), openMAXIMS, which includes all of the enhancements made for Taunton and Somerset NHS Foundation Trust. Taunton was the first trust to go live with the software and has been working closely with IMS MAXIMS on the new functionality.

Aridhia has announced that it is among 36 organisations behind a ground-breaking Innovative Medicines Initiative research programme that aims to build a platform for efficient testing of innovative treatments for the prevention of Alzheimer's dementia.